Raziuddin S, Shetty S, Ibrahim A, Patil K
Department of Clinical Immunology and Urology, King Saud University, College of Medicine, Abha, Saudi Arabia.
Cancer. 1990 Feb 15;65(4):931-9. doi: 10.1002/1097-0142(19900215)65:4<931::aid-cncr2820650419>3.0.co;2-4.
Patients with schistosomiasis of the urinary bladder (SB) associated with carcinoma of the bladder (SCB) or carcinoma of the prostate (SCP) have a variety of immunologic abnormalities, including the presence of HLA-DR+ and interleukin-2 receptor-positive (IL-2R+) T-lymphocytes in circulating blood. This study demonstrated that, the HLA-DR+ and IL-2R+ antigens are selectively expressed on majority of the CD4+ T-lymphocytes of patients with SCB, whereas, these antigens are expressed almost equally on both CD4+ and CD8+ T-lymphocytes of patients with SB and SCP. Expressions of HLA-DR+ and IL-2R+ antigens in CD4+ T-lymphocytes, and a depressed response of this T-cell subset to phytohemagglutinin and Concanavalin A stimulations seems to be the characteristic feature of these patients with SCB. In addition, the autologous mixed lymphocyte reaction (AMLR) and allogenic mixed lymphocyte reaction (MLR) was depressed in patients with SCB. However, patients with SCP demonstrated a normal MLR, even though the AMLR was highly depressed. The immunoregulatory role of the HLA-DR+, IL-2R+, CD4+ helper/inducer T-lymphocytes, and the AMLR and MLR abnormalities we have identified in patients with SCB may be important and could play a role in the pathobiology of these diseases in humans.
患有与膀胱癌(SCB)或前列腺癌(SCP)相关的膀胱血吸虫病(SB)的患者存在多种免疫异常,包括循环血液中存在HLA - DR +和白细胞介素 - 2受体阳性(IL - 2R +)的T淋巴细胞。本研究表明,HLA - DR +和IL - 2R +抗原在SCB患者的大多数CD4 + T淋巴细胞上选择性表达,而在SB和SCP患者的CD4 +和CD8 + T淋巴细胞上这些抗原几乎等量表达。CD4 + T淋巴细胞中HLA - DR +和IL - 2R +抗原的表达以及该T细胞亚群对植物血凝素和刀豆球蛋白A刺激的反应降低似乎是这些SCB患者的特征。此外,SCB患者的自体混合淋巴细胞反应(AMLR)和同种异体混合淋巴细胞反应(MLR)降低。然而,SCP患者的MLR正常,尽管AMLR高度降低。我们在SCB患者中确定的HLA - DR +、IL - 2R +、CD4 +辅助/诱导性T淋巴细胞的免疫调节作用以及AMLR和MLR异常可能很重要,并可能在这些人类疾病的病理生物学中起作用。